Literature DB >> 29463127

Tin Ring Splint Treatment for Osteoarthritis of the Distal Interphalangeal Joints.

Kaoru Tada1, Yasumitsu Toribatake1, Daiki Yamamoto1, Tadahiro Nakajima1, Mika Nakada1, Masashi Matsuta1, Hiroyuki Tsuchiya1.   

Abstract

Background: We made a tin ring splint for osteoarthritis of the distal interphalangeal joint that looks attractive and is easy to wear. We report the treatment results with this splint.
Methods: We enrolled 30 patients with painful osteoarthritis of the distal interphalangeal joint in this study. A tin ring splint was made with tin alloy containing small quantities of silver. Patients were instructed to wear the splint when they felt pain. Patients were assessed before splint use and after 1, 3, and 6 months of splint use. Endpoints included the numeric pain scale, active arc of motion of the distal interphalangeal joint, Hand 20, functional assessment criteria of the upper extremities, and treatment satisfaction. In addition, data were collected on time to symptom relief and satisfaction related to usability and appearance of the splint (0 = dissatisfied, 10 = satisfied).
Results: The numeric pain scale showed significant pain improvement from 58.4 ± 4.1 at baseline to 33.1 ± 4.5 at 1 month, and the Hand 20 score also showed significant improvement from 35.0 ± 4.3 at baseline to 20.2 ± 3.2 after 6 months. Active arc of motion were not changed significantly. Most patients responded that symptoms were relieved by the 10th day after treatment. Satisfaction related to usability was 8.9 ± 0.3, and appearance was 7.6 ± 0.4. Conclusions: A tin ring splint quickly reduced pain, and satisfaction related to usability and appearance was high. This splint could be one choice for conservative treatment of osteoarthritis of the distal interphalangeal joint.

Entities:  

Keywords:  conservative therapy; distal interphalangeal joint; osteoarthritis; splint; tin

Mesh:

Substances:

Year:  2018        PMID: 29463127      PMCID: PMC6759981          DOI: 10.1177/1558944718760003

Source DB:  PubMed          Journal:  Hand (N Y)        ISSN: 1558-9447


  7 in total

1.  Radiological assessment of osteo-arthrosis.

Authors:  J H KELLGREN; J S LAWRENCE
Journal:  Ann Rheum Dis       Date:  1957-12       Impact factor: 19.103

2.  Joint-specific prevalence of osteoarthritis of the hand.

Authors:  F V Wilder; J P Barrett; E J Farina
Journal:  Osteoarthritis Cartilage       Date:  2006-06-08       Impact factor: 6.576

3.  Custom-made splint treatment for osteoarthritis of the distal interphalangeal joints.

Authors:  Masayoshi Ikeda; Takayuki Ishii; Yuka Kobayashi; Joji Mochida; Ikuo Saito; Yoshinori Oka
Journal:  J Hand Surg Am       Date:  2010-04       Impact factor: 2.230

4.  Prevalence, incidence and progression of hand osteoarthritis in the general population: the Framingham Osteoarthritis Study.

Authors:  Ida K Haugen; Martin Englund; Piran Aliabadi; Jingbo Niu; Margaret Clancy; Tore K Kvien; David T Felson
Journal:  Ann Rheum Dis       Date:  2011-05-27       Impact factor: 19.103

5.  Patients' perceptions of the treatment and management of hand osteoarthritis: a focus group enquiry.

Authors:  Susan Hill; Krysia S Dziedzic; Bie Nio Ong
Journal:  Disabil Rehabil       Date:  2011       Impact factor: 3.033

6.  Prevalence of hand osteoarthritis and its relationship to hand pain and grip strength in Japan: The third survey of the ROAD study.

Authors:  Rie Kodama; Shigeyuki Muraki; Hiroyuki Oka; Toshiko Iidaka; Masatoshi Teraguchi; Ryohei Kagotani; Yoshiki Asai; Munehito Yoshida; Yutaka Morizaki; Sakae Tanaka; Hiroshi Kawaguchi; Kozo Nakamura; Toru Akune; Noriko Yoshimura
Journal:  Mod Rheumatol       Date:  2016-02-16       Impact factor: 3.023

7.  Night-time immobilization of the distal interphalangeal joint reduces pain and extension deformity in hand osteoarthritis.

Authors:  Fiona E Watt; Donna L Kennedy; Katharine E Carlisle; Andrew J Freidin; Richard M Szydlo; Lesley Honeyfield; Keshthra Satchithananda; Tonia L Vincent
Journal:  Rheumatology (Oxford)       Date:  2014-02-08       Impact factor: 7.580

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.